Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  16,132 results for ""Hepacivirus""

Your Filters

Language : english Subject : hepacivirus Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus.

  • Authors : Nardini R; Istituto Zooprofilattico Sperimentale del Lazio e della Toscana 'M. Aleandri', 00178 Rome, Italy.; Pacchiarotti G

Subjects: Horse Diseases*/Horse Diseases*/Horse Diseases*/virology ; Horse Diseases*/Horse Diseases*/Horse Diseases*/epidemiology ; Phylogeny*

  • Source: Viruses [Viruses] 2024 Apr 16; Vol. 16 (4). Date of Electronic Publication: 2024 Apr 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Hepatitis C Virus Dysregulates Polyamine and Proline Metabolism and Perturbs the Urea Cycle.

  • Authors : Zakirova NF; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.; Khomich OA

Subjects: Proline*/Proline*/Proline*/metabolism ; Hepacivirus*/Hepacivirus*/Hepacivirus*/physiology ; Hepacivirus*/Hepacivirus*/Hepacivirus*/drug effects

  • Source: Cells [Cells] 2024 Jun 14; Vol. 13 (12). Date of Electronic Publication: 2024 Jun 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read More Add to Saved list
×
Academic Journal

Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy.

  • Authors : Miura M; Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.; Nishino M

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Programmed Cell Death 1 Receptor* ; Hepacivirus*/Hepacivirus*/Hepacivirus*/drug effects

  • Source: PloS one [PLoS One] 2024 May 23; Vol. 19 (5), pp. e0299424. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development.

  • Authors : Pierce BG; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.

Subjects: Hepacivirus*/Hepacivirus*/Hepacivirus*/immunology ; Hepacivirus*/Hepacivirus*/Hepacivirus*/genetics ; Hepacivirus*/Hepacivirus*/Hepacivirus*/chemistry

  • Source: Viruses [Viruses] 2024 May 18; Vol. 16 (5). Date of Electronic Publication: 2024 May 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Determination of hepatitis C virus subtype prevalent in Sindh, Pakistan: a phylogenetic analysis.

  • Authors : Farooq S; Mediagnost Gesellschaft Für Forschung Und Herstellung Von Diagnostika, Reutlingen, Germany. .; National Institute of Virology, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center of Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan. .

Subjects: Phylogeny* ; Hepacivirus*/Hepacivirus*/Hepacivirus*/genetics ; Hepacivirus*/Hepacivirus*/Hepacivirus*/isolation & purification

  • Source: Scientific reports [Sci Rep] 2024 May 15; Vol. 14 (1), pp. 11159. Date of Electronic Publication: 2024 May 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection.

  • Authors : Pewkliang Y; Faculty of Medicine Ramathibodi Hospital, Program in Translational Medicine, Mahidol University, Rama VI Road, Rajathevi, Bangkok, Thailand.; Thongsri P

Subjects: Hepatocytes*/Hepatocytes*/Hepatocytes*/virology ; Hepatocytes*/Hepatocytes*/Hepatocytes*/pathology ; Hepacivirus*/Hepacivirus*/Hepacivirus*/genetics

  • Source: PloS one [PLoS One] 2024 May 13; Vol. 19 (5), pp. e0303265. Date of Electronic Publication: 2024 May 13 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

PSPC1 Binds to HCV IRES and Prevents Ribosomal Protein S5 Binding, Inhibiting Viral RNA Translation.

  • Authors : Tripathi SK; Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, Karnataka, India.; Aneja A

Subjects: Hepacivirus*/Hepacivirus*/Hepacivirus*/genetics ; Hepacivirus*/Hepacivirus*/Hepacivirus*/physiology ; Ribosomal Proteins*/Ribosomal Proteins*/Ribosomal Proteins*/metabolism

  • Source: Viruses [Viruses] 2024 May 07; Vol. 16 (5). Date of Electronic Publication: 2024 May 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Hepacivirus*/Hepacivirus*/Hepacivirus*/genetics

  • Source: Scientific reports [Sci Rep] 2024 May 03; Vol. 14 (1), pp. 10244. Date of Electronic Publication: 2024 May 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Proximity labeling of host factor ANXA3 in HCV infection reveals a novel LARP1 function in viral entry.

  • Authors : Bley H; Institute of Virology, Philipps-University Marburg, Marburg, Germany.; Krisp C

Subjects: Annexin A3*/Annexin A3*/Annexin A3*/metabolism ; Annexin A3*/Annexin A3*/Annexin A3*/genetics ; Hepacivirus*/Hepacivirus*/Hepacivirus*/metabolism

  • Source: The Journal of biological chemistry [J Biol Chem] 2024 May; Vol. 300 (5), pp. 107286. Date of Electronic Publication: 2024 Apr 16.Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication

Record details

Read More Add to Saved list
×
Academic Journal

Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China.

  • Authors : Li H; Zhuhai Center for Disease Control and Prevention, Zhuhai, Guangdong, China.; School of Public Health, Jinan University, Guangzhou, Guangdong, China.

Subjects: Hepatitis C*/Hepatitis C*/Hepatitis C*/epidemiology ; Hepatitis C*/Hepatitis C*/Hepatitis C*/transmission ; Hepatitis C*/Hepatitis C*/Hepatitis C*/virology

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Apr 29; Vol. 24 (1), pp. 451. Date of Electronic Publication: 2024 Apr 29.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  16,132 results for ""Hepacivirus""